Clinical Trials Logo

Clinical Trial Summary

Patients who have completed have completed a cumulative dose of >=120miligram/kilogram oral isotretinoin within the last 30 days, and has mild to moderate acne scarring will be randomized, into a right-left comparison study using Fraxel DUAL (Solta Medical) laser on one side of the face, and no treatment on the other side of the face. Subejcts will receive treatments at week 0, week 4, and week 8. Photographs will be taken after each treatment, 7 days after each treatment, and 4 months after last treatment. Photographs will be reviewed by blind assessors who will analyze the pre- and post-treatment photographs to measure change.


Clinical Trial Description

Approximately 15 patients who are over 18 years or older, have completed a cumulative dose of >=120miligram/kilogram oral isotretinoin within the last 30 days, and has mild to moderate acne scarring will be randomized, into a right-left comparison study.

One side of the face will be randomized to NAFR treatment and other side to control (no treatment) using a random number generator. Subjects will apply topical anesthetic (Benzocaine / Lidocaine / Tetracaine 20% / 8% / 4% Ointment) to the entire face one hour prior to treatment. The NAFR operator will be notified of which side is to be treated with NAFR.

To ensure blinded evaluations, the same unblinded investigator will perform all the laser treatments, whereas efficacy evaluations will be performed by two trained and experienced evaluators who are blinded to the treatment assignment. Evaluations for adverse effects will be carried out by the unblinded NAFR (during and immediately post treatment) and the two blinded investigators at prescribed intervals.

Treatments:

Laser procedure will be performed to the entire assigned half of the face with Fraxel DUAL (Solta Medical) with the following settings: 1550 nanometer; 35 to 40 millijoules/microthermal zone, treatment level from 7 to 10, corresponding to treatment coverage of 20% to 35%. The treatment protocol was modified slightly depending on the individual scar characteristics (depth, width, and type).

The patients will receive a total of three laser treatments using NAFR. Successive treatments will be separated by 1 month. During all treatments, pain will be assessed as ''mild, moderate, or severe.'' Post-treatment instructions will include the use of a mild soap, sunscreen in the morning, and a non-comedogenic moisturizing cream in the evening twice daily for three days. Oral valacyclovir (1 gram daily) will be prescribed for patients for prophylaxis of herpetic infection.

Evaluations:

Photographic documentation using identical camera settings, lighting, and patient positioning will be obtained at baseline, before each treatment session, 7-days after each session, and 4 months after the final treatment.

Primary Efficacy Measure:

Wound healing will be assessed after 7 days of each treatment and at the end of the study (4 month after last treatment) in all patients. This will be performed by 2 blinded evaluators who will analyze the pre and post-treatment photographs.

Secondary Efficacy Measure:

Secondary study endpoints will be improvement of acne scarring, assessment of treatment tolerability (adverse effects, pain assessment, and patient satisfaction and preference.

Improvement in acne scarring will be graded by two independent blinded physicians using a quartile grading scale (1 = 1% to 25%, 2 =26% to 50%, 3 =51% to 75%, 4 = >76%). All grading physicians will be blinded to the total number of treatments and which photographs were baseline and follow-up at 4 month after last treatment.

Evaluations for immediate and delayed adverse effects of the treatments, including erythema, edema, blistering, crusting, scarring, and hyperpigmentation, graded on a 4-point scale (0 = absent, 1= mild, 2 = moderate, and 3 = severe) will be carried out at each visit.

Patients will also assess the intensity of pain post-treatment using a visual analogue scale (VAS) (0 = absence of pain, 10 = most-severe pain).

Patient assessment of efficacy would be reflected by their judgment of which side of the face responded best to treatment. Patient preference can then be assessed at the end of the study asking, "would you recommend NAFR treatment for acne scarring to others?" ;


Study Design


Related Conditions & MeSH terms

  • Acne Scars - Mixed Atrophic and Hypertrophic
  • Hypertrophy

NCT number NCT03514771
Study type Interventional
Source University of Utah
Contact
Status Completed
Phase N/A
Start date January 28, 2016
Completion date June 14, 2017

See also
  Status Clinical Trial Phase
Completed NCT04559022 - Pilot Study Investigating the Efficacy of Fat Grafting as a Treatment for Male and Female Facial Acne Scarring N/A
Active, not recruiting NCT06192550 - Functional Usability and Feasibility Testing of the Profound Matrix™ System N/A
Recruiting NCT05362929 - Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color N/A
Recruiting NCT05597267 - The MIRIA Acne Scar Study N/A
Completed NCT05691049 - Evaluation of Efficacy and Safety of HCC_45 for the Correction of Acne Scars of the Face N/A
Active, not recruiting NCT02592993 - Performance of PicoWayTM Picosecond Fractional Laser for Acne Scars N/A
Completed NCT04827680 - Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring N/A
Completed NCT03988049 - Comparison of 1,550 and 755 Laser in a Split-face Trial N/A
Not yet recruiting NCT05597813 - Topical Timolol 0.5% in Atrophic Acne Scar N/A
Completed NCT03284333 - enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars N/A
Not yet recruiting NCT06102343 - Safety and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER:Glass 1540nm Laser Module in the Treatment of Acne Scars. N/A
Not yet recruiting NCT05600075 - Microneedling With Topical Preparations in the Treatment of Atrophic Post-acne Scars N/A
Not yet recruiting NCT04252352 - Treatment of Acne Scars With Fractional CO2 Laser Versus Radio-frequency Microneedling N/A
Completed NCT04606134 - Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring N/A
Completed NCT05358860 - Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement N/A
Completed NCT04057768 - Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles N/A